设为首页| 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 联系我们 下载专区
最新消息:
位置:首页 >> 期刊文章
微小RNA与原发性肝癌的研究进展
作者:李子英  卢再鸣  赵相轩  李慧  郭启勇 
单位:中国医科大学附属盛京医院 放射科 沈阳 110004 
关键词:miRNA 原发性肝癌 细胞增殖 细胞凋亡 
分类号:
出版年,卷(期):页码:2015,7(4):8-10
摘要:

摘要:微小RNA(microRNA,miRNA)是非编码的内源性小分子RNA,长度为21~25个核苷酸。
微小RNA可与目标mRNA的3’-非翻译区进行互补结合,使得mRNA被降解而表达受到抑制,从而使
得相应调控基因沉默。miRNA在诸多生理和病理过程中发挥重要作用。近年来,研究发现miRNA与
肿瘤细胞增殖和凋亡相关,其多在肿瘤组织中异常表达,参与肿瘤的发生发展。主要分为“原癌性
miRNA”和“抑癌性miRNA”。除表达水平外,miRNA碱基序列所发生的改变也可导致肿瘤的发
生。本文主要就miRNA在原发性肝癌中的研究现状做相关综述,以期为未来进一步研究miRNA在肝
癌中的作用和应用提供有益线索。

Abstract: MicroRNAs (miRNAs) are a group of endogenous small noncoding RNAs, approximately
21~25 nucleotides in length. In mammals, their function is mainly repressing the mRNA transcripts via
imperfect complementary sequences in the 3’-UTR of target mRNAs. miRNAs play important roles in many
physiological and pathological processes. Over the past decades, overwhelming studies have reported that
miRNAs are associated with the proliferation and apoptosis of tumor cells. miRNAs aberrantly expressed in
tumor tissues have significant roles in tumor induction, progression and recurrence. Depending on miRNA
function and status in cancer, miRNAs are generally classified as tumor suppressor or onco-miRNAs. In
addition to the deregulated expression levels and potentially mutations that altering a miRNA seed sequence
could ablate target repression by tumor-suppressive miRNAs or allow for altered target selection, which could
contribute to oncogenesis. In this review, an overview on the miRNAs study in primary liver cancer were
given so as to provide useful clues to understand the significance of miRNAs in the future.

基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 

地址:北京市朝阳区京顺东街8号
邮政编码:100015  电话:010-84322058  传真:010-84322059 Email:editordt@163.com